Patents work for protecting the investment in development and clinical trials, sure, but do they work optimally? Are there better ways to finance these processes?

Keep in mind that the cost way pay for these patents is a dramatically higher price for life-saving (or life-improving) treatments. Could we not cut out the middle-man and redirect a portion of those higher costs to fund research and clinical trials directly (i.e. in the form of taxes)?